Form 4 holding
Chief Financial Officer
Kyverna Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 10,000
- Estimated value
- $81,000
- Report date
- 13 Mar 2026
- Price
- $8.10
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|